🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › South Carolina › Charleston

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Charleston, SC

Tha 6 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air Charleston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

A’ fastadhÌre 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

A’ fastadhÌre 2
  • Medical University of South Carolina Hollings Cancer Center,, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07743190

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

A’ fastadhÌre 1
  • Normunity Investigational Site, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

A’ fastadhÌre 2
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06845319

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

A’ fastadhÌre 2
  • Medical University of South Carolina, Charleston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Gibl 2026 · NCT04468061

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Charleston

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.